Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Briefings
-
Cytomegalovirus Retinitis: The neglected disease of the AIDS pandemic
In this briefing document, MSF calls for action at both international and national levels to address current shortcomings in the diagnosis and treatment of cytomegalovirus retinitis (CMVR). CMVR is a preventable disease caused by a virus (cytomegalovirus or CMV) that attacks the retina of the eye in patients with suppressed immune systems, specifically those infected with HIV. If untreated, the disease can lead to total and irreversible blindness.
Last updated 23 May 2013
www.msfaccess.org/content/cytomegalovirus-retinitis-neglected-disease-aids-pandemic -
Buruli Ulcer: Ending the Neglect of a Disease That Impacts the Young
Buruli ulcer disease is a serious skin infection which if untreated can lead to disfiguring and disabling lesions. This neglected tropical disease is mainly endemic in western Africa, although it has been reported elsewhere in Africa, the Americas, Australia and Japan. It affects communities living along slow-flowing bodies of water such as ponds, swamps and lakes. People with HIV and the young appear to be most at-risk, with most patients being under 15 years of age.
Last updated 26 March 2013
www.msfaccess.org/content/buruli-ulcer-ending-neglect-disease-impacts-young -
Combating Kala Azar: treatment is possible even in remote settings
Last updated 15 March 2013
www.msfaccess.org/content/combating-kala-azar-treatment-possible-even-remote-settings -
Briefing Note: Trading Away Health: The Trans-Pacific Partnership Agreement (TPP)
2013 Briefing Note The Trans-Pacific Partnership (TPP) trade deal is currently being negotiated between the US and ten other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. The agreement is slated to further expand its membership, potentially to all 21 Asia Pacific APEC nations.
Last updated 19 February 2013
www.msfaccess.org/content/trading-away-health-trans-pacific-partnership-agreement-tpp -
Trading Away Health: What to Watch Out for in Free Trade Agreements
Generic competition saves lives. High medicine prices hurt patients and restrict the capacity of governments and other treatment providers to respond to medical needs. India’s contribution to the health of the developing world cannot be underestimated. Current and future free trade agreement (FTA) negotiations between India and certain developed countries threaten to tighten the screws on the production and export of affordable essential medicines so that they are once more priced out of reach.
Last updated 7 February 2013
www.msfaccess.org/content/trading-away-health-what-watch-out-free-trade-agreements -
The Enforcement Provisions of the EU-India FTA: Implications for Access to Medicines
MSF briefing document outlining what concerns MSF when it comes to the enforcement provisions in the EU-India FTA negotiations. Excerpt:
Last updated 18 January 2013
www.msfaccess.org/content/enforcement-provisions-eu-india-fta-implications-access-medicines -
Why South Africa Should Examine Pharmaceutical Patents
How legislative reform could boost the affordability and accessibility of medicines for South Africans
Last updated 11 January 2013
www.msfaccess.org/content/why-south-africa-should-examine-pharmaceutical-patents -
Issue Brief: Easier-to-use vaccines are needed for hard-to-reach children
Immunisation is one of the most effective ways of saving young lives, yet every year one in five children born – 22 million – is left without this basic protection from disease. Why?
Last updated 29 November 2012
www.msfaccess.org/content/issue-brief-easier-use-vaccines-are-needed-hard-reach-children -
Issue Brief: Vaccines: The price of protecting a child from killer diseases
Each year, the lives of two and a half million children are saved because they are protected against killer diseases through vaccination. Vaccinating with new vaccines should save many more lives, but high prices could prevent this from happening.
Last updated 29 November 2012
www.msfaccess.org/content/issue-brief-vaccines-price-protecting-child-killer-diseases -
Issue Brief: Vaccines: Ensuring sustainable supplies
Over the last few years, new vaccines to fight an increased range of childhood diseases have come to market. These new products come at a time when there is a renewed focus and international commitment to ensure that children in developing countries are also able to benefit from full protection against childhood killer diseases.
Last updated 29 November 2012
www.msfaccess.org/content/issue-brief-vaccines-ensuring-sustainable-supplies
Pages
